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Abstract We have isolated a new MT-MMP related gene of 
3.3 kb from a mouse lung cDNA library using a human MT1-
MMP cDNA as a probe. The deduced protein sequence shows 
87% homology to human MT2-MMP and 52, 50 and 29% to 
MT1-MMP, MT3-MMP and MT4-MMP, respectively. Thus 
the gene is thought to be a mouse homologue of human MT2-
MMP. A monoclonal antibody raised against a synthetic peptide 
recognized mouse MT2-MMP as a 70 kDa protein. Like MT1-
and MT3-MMPs, mouse MT2-MMP caused activation of pro-
gelatinase A upon co-transfection into COS-1 cells. 
Key words: Matrix metalloproteinase; Membrane type 
matrix metalloproteinase; M T 2 - M M P ; 
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1. Introduction 
Matrix metalloproteinases (MMPs) are zinc-binding endo-
peptidases that degrade macromolecules of extracellular ma-
trix (ECM). Recently four membrane-type matrix metallopro-
teinases (MT-MMPs) have been identified using the RT -PCR 
technique and primers corresponding to the conserved regions 
of M M P genes [1-6]. They contain a t ransmembrane domain 
and a short cytoplasmic tail downstream of the hemopexin-
like domain. P ro -MT-MMPs like prostromelysin-3 contain a 
conserved sequence of four basic amino acid residues between 
propeptide and catalytic domains that is a potential cleavage 
site of preprotein convertase, furin [1]. Indeed, furin was dem-
onstrated to cleave this sequence in prostromelysin-3 and 
p r o M T l - M M P resulting in enzyme activation [7-9]. Thus ac-
tivation of M T - M M P s seems to be regulated differently from 
other M M P s [10]. 
M T 1 - M M P induces autocatalytic activation of pro-gelatin-
ase A by introducing a cleavage into the propeptide domain 
[8,9,11,12] at the reported N-terminus of the intermediate 
form [13] and also degrades E C M components [8,14]. Other 
M T - M M P s remain to be characterized biochemically 
although M T 3 - M M P was shown to also activate pro-gelatin-
ase A [4]. Characterization of mouse M T - M M P genes is an 
important step in future analysis of the biological functions of 
these enzymes by generating knock-out and transgenic mice. 
Here we report isolation of a new mouse MT-MMP gene that 
eventually turned out to be the mouse homologue of human 
MT2-MMP. The gene product was identified using a mono-
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clonal antibody raised against a synthetic peptide and its abil-
ity to activate progelatinase A was also demonstrated for the 
first time. 
2. Materials and methods 
2.1. Screening of a cDNA library and molecular cloning 
A XgtlO cDNA library of mouse lung (Clontech, Palo Alto, CA) 
was screened with a human MT1-MMP cDNA (accession number 
D26512) fragment (1-1485 bp) as a probe [2]. Phage plaques were 
transferred to nitrocellulose filters, hybridized with the 32P-labeled 
probe at 60°C in Rapid Hybridization buffer (Amersham) and washed 
with 0.5XSSC, 0.1% SDS at 50°C. DNA inserts of the purified phages 
were excised with EcoKl and subcloned into a pBluescript vector. 
Nucleotide sequence was determined using an automated sequencer 
(Applied Biosystems model 373A DNA sequencer). 
2.2. Cell culture and transfection 
Cells were cultured in Dulbecco's modified Eagle's medium 
(DMEM) containing 5% fetal calf serum and 2 mM glutamine under 
a 5% CO2 atmosphere. Transfection of the cells has been carried out 
using a calcium phosphate method as described previously [15]. For 
expression of the cloned gene, an eukaryotic expression vector, pSG5 
(Stratagene, La Jolla, CA), that has a SV40 early gene promoter was 
used. Lysates of the COS-1 cells transfected with MT-MMP plasmids 
were prepared and examined by Western blotting as described previ-
ously [1]. 
2.3. Monoclonal antibodies and Western blotting 
Mouse monoclonal antibodies were raised against MT-MMP de-
rived synthetic peptides. Monoclonal antibodies 113-15E [1] and 
117-4E3 [4] were against C319DGNFDTVAMLRGEMA333 and 
F166EEVPYSELENGKRD181 peptides of human MT1-MMP [1] 
and anti-MT3-MMP [4] respectively. For mouse MT2-MMP, 
T282DNFQLPEDDLRGI295 peptide was synthesized and used for im-
munization of mice to obtain a monoclonal antibody 162-4E3. West-
ern blot analysis of the COS-1 cell lysates was performed as described 
[1]-
2.4. Gelatin zymography 
Samples were mixed with the SDS sample buffer in the absence of a 
reducing agent, incubated for 2 Omin at 37°C and separated on a 10% 
polyacrylamide gel containing 0.1% gelatin. After electrophoresis, gels 
were soaked in 2.5% Triton X-100 for 1 h and incubated in 50 mM 
Tris-HCl (pH 7.6) containing 150 mM NaCl, 10 mM CaCl2, and 
0.02% NaN3 at 37°C for 24 h. The gels were stained with 0.1% Coo-
massie brilliant blue R250, and the location of gelatinolytic activity 
was detected as clear bands on the background of uniform staining 
[1]. 
3. Results and discussion 
To isolate a mouse MT1-MMP and its related genes we 
screened a mouse lung c D N A library with the human MT1-
MMP c D N A fragment as a probe and obtained eight positive 
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CGGACTCCCCTTTCTCTGACTCTGGAGC 28 n 
ATGGGCAGCGACCGGAGCGCACTCGGACGTCCAGGCTGCACTGGCAGCTGCCTCAGCAGCCGAGCTTCGCTGCTCCCGCTGCTACTGGTG 118 
MetGlySerAspArgSerAlaLeuGlyArgProGlyCysThrGlySerCysLeuSerSerArgAlaSerLeuI^euProLeuLeuLeuVal 30 a a 
CTTCTGGACTGTCTGGGCCATGGTACAGCGTCTAAAGACGCCGAAGTGTACGCCGCGGAGAACTGGCTGCGGCTCTATGGCTACCTACCC 208 
LeuLeuAspCysLeuGlyHisGlyThrAlaSerLysAspAlaGluValTyrAlaAlaGluAsnTrpLeuArgLeuTyrGlyTyrLeuPro 60 
CAGCCCAGCCGCCACATGTCCACCATGCGCTCTGCCCAGATCCTGGCCTCCGCCCTTGCCGAGATGCAGAGTTTCTATGGGATCCCTGTC 298 
GlnProSerArgHisMetSerThrMetArgSerAlaGlnlleLeuAlaSerAlaLeuAlaGluffetGlnSerPheTyrGlylleProVal 90 
ArCKGTGTGCTTGATGAAGAGACGAAAACGTGGATGAAGCGGCCCCGATGTGGGGTTgCTGATCAGTTTGGGGTACATGTGAAAGCCAAC 388 
ThrGlyValLeuAspGluGluThrLyBThrTrpMetLysArt^roArqCysGlyValProAsHGlnPheGlyValHisValLysAlaABn 120 
CTGCGTCGACGGCGGAAACGTTACACCCTGACAGGAAAGGCATGGAACAATTACCACCTGACCTTCAGCATCCAGAACTACACTGAGAAG 478 
LeuArgArgArgArgLysArgTyrThrLeuThrGlyLysAlaTrpAsnAsnTyrHisLeuThrPheSerlleGlnAsnTyrThrGluLys ^50 
CTGGGCTGGTACAACTCCATGGAGGCGGTGCGCAGGGCTTTCCAAGTGTGGGAGCAGGTCACACCATTGGTCTTCCAGGAAGTATCCTAT 568 
LeuGlyTrpTyrAsnSerMetGluAlaValArgArgAlaPheGlnValTrpGluGlnValThrFroLeuValPheGlnGluValSerTyr 180 
GATGACATTCGGCTACGAAGGCGAGCGGAGGCTGACATCATGGTACTCTTTGCCTCTGGCTTCCATGGCGACAGCTCACCGTTTGATGGC 658 
AspAspIleArgLeuArgArgArgMaGluAlaAspIleMetValLeuPheAlaSerGlyPheHisGlyAspSerSerProPheAspGly 210 
GTGGGTGGCTTTCTGGCCCACGCTTATTTCCCCGGCCCTGGTCTGGGTGGGGACACCCATTTCGACGCAGATGAACCCTGGACCTTCTCC 748 
ValGlyGlyPheLeuAlaHisAlaTyrPheProGlyProGlyLeuGlyGlyAspThrHi3PheA3pAlaAspGluProTrpThrPheSer 240 
AGCACTGACCTGCATGGAATCAGCCTCTTTCTGGTGGCCGTGCATGAGCTGGGCCATGCCCTGGGGCTAGAACACTCAAGTAACCCCAGC 838 
SerThrAspLeuHisGlylleSerLeuFheLeuValAlaValHisGluLeuGlvHisAlaLeuGlvLeuGluHisSerSerABnProSer 270 
GCTATTATGGCACCCTTCTACCAGTGGATGGATACCGACAACTTCCAGCTGCCCGAAGATGACCTTCGGGGCATCCAGCAGCTGTATGGC 928 
AlalleMetAlaProPheTyrGlnTrpMetAspThrAspAsnPheGlnLeuProGluAspAspLeiiArgGlylleGlnGlnLeuTyrGly 300 
TCCCCAGATGGTAAGCCACAGCCCACCCGGCCTCTCCCCACTGTAAGGCCCCGGCGGCCAGGACGGCCAGATCACCAGCCACCTCGGCCT 1018 
SerProAspGlyLysProGlnProThrArgProLeuProThrValArgProArgArgProGlyArgProAspHisGlnProProArgPro 330 
CCCCAGCCACCACATCCAGGTGGGAAGCCAGAAAGGCCCCCCAAACCAGGGCCCCCACCCCAGCCCCGAGCCACAGAGAGGCCTGACCAG 1108 
ProGlnProProHisProGlyGlyLysProGluArgProProLysProGlyProProProGlnProArgAlaThrGluArgProAspGln 350 
TATGGCCCCAACATCTGCGATGGCAACTTCGACACAGTGGCTGTGCTCCGCGGAGAGATGTTTGTGTTCAAGGGCCGCTGGTTCTGGCGA H 9 8 
TyrGlyProAsnlleCysAspGlyAsnPheAspThrValAlaValLeuArgGlyGluMetPheValPheLysGlyArgTrpPheTrpArg 390 
GTCAGGCACAACCGCGTTCTAGACAACTACCCCATGCCAATTGGCCACTTCTGGCGCGGTCTGCCGGGGAACATCAGTGCTGCCTACGAG 1288 
ValArgHisAsnArgValLeuAspAsnTyrProMetProIleGlyHisPheTrpArgGlyLeuProGlyAsnlleSerAlaAlaTyrGlu 420 
CGCCAGGATGGACATTTTGTCTTCTTCAAAGGTAACCGCTACTGGCTTTTCCGAGAAGCCAATCTGGAGCCCGGCTACCCACAGCCGCTG 1378 
ArgGlnAspGlyHisPheValPhePheLysGlyAsnArgTyrTrpLeuPheArgGluAlaAsnLeuGluProGlyTyrProGlnProLeu 450 
AGCAGCTATGGCACAGACATCCCCTATGACCGCATTGACACAGCCATCTGGTGGGAGCCCACAGGTCACACCTTCTTCTTTCAAGCAGAC 1468 
SerSerTyrGlyThrAspIleProTyrAspArglleAspThrAlalleTrpTrpGluProThrGlyHisThrPhePhePheGlnAlaAsp 480 
AGGTACTGGCGCTTCAACGAGGAGACACAGCATGGAGACCCTGGCTACCCCAAGCCCATCAGTGTCTGGCAGGGGATCCCCACCTCTCCC 1558 
ArgTyrTrpArgPheAsnGluGluThrGlnHisGlyAspProGlyTyrProLysProIleSerValTrpGlnGlylleProThrSerPro 510 
AAAGGGGCCTTCCTCAGCAACGATGCAGCCTACACCTACTTCTACAAGGGCACCAAGTACTGGAAATTCAACAACGAACGCCTACGGATG 1648 
LysGlyAlaPheLeuSerAsnAspAlaAlaTyrThrTyrPheTyrLysGlyThrLysTyrTrpLysPheAsnAsnGluArgLeuArgMet 540 
GAACCCGGCCACCCCAAATCCATCCTGCGGGACTTCATGGGCTGCCAGGAGCACGTGGAGCCCCGATCGCGATGGCCCGATGTGGCTCGT 1738 
GluProGlyHisProLysSerlleLeuArgAspPheMetGlyCysGlnGluHisValGluProArgSerArgTrpProAspValAlaArg 570 
CCACCCTTCAACCCCAACGGGGGTGCCGAGCCTGAGGCAGATGGTGACAGCAAGGAAGAGAACGCGGGTGACAAGGATGAGGGCAGCCGC 1828 
ProProPheAsnProAsnGlyGlyAlaGluProGluAlaAspGlyAspSerLysGluGluAsnAlaGlyAspLysAspGluGlySerArg goo 
GTGGTGGTGCAGATGGAGGAGGTGGTCCGGACAGTGAACGTGGTGATGGTGTTGGTCCCCTTGCTGCTGTTGCTCTGTATTCTGGGCCTG 1918 
ValValValGlnMetGluGluValValArgThrValAsnValValMetValLeuValProLeuLeuLeuLeuLeuCysIleLeuGlyLeu 630 
GCCTTTGCTCTGGTGCAGATGCAGCGCAAGGGCGCCCCTCGCATGCTGCTCTACTGCAAGCGCTCACTGCAGGAGTGGGTGTGATCAGGT 20U8 
AlaPheAlaLeuValGlnMetGlnArgLysGlyAlaProArgMetLeuLeuTyrCyBLysArgSerLeuGlnGluTrpVal 657 
AGCACCCGCAGCACCCGGTGCTCAGGTCTGCAGGGACAGGAGACGTGTGGATCCCAGATGCTCCCTCGGCGCGGCAGGATGCCTCCTAGC 2098 
CACACACATCCCCCTGCCAGCCTTGCCCCCCACCCCCGTCCTCCTTTATTTATGCCCAGGTGCCTCTTCTTTTTGGCACCCTCTCTCAGC 2188 
CTTTGGTTCCGCTTTCCTGACTCGGGCCAGGAGATGCTTTGAGATCTCCCGGAGTGTAGTACCGCCCCAGGCAGGAACGAAGGGACAGAG 2278 
GCTCACACCTCTGGAAGATGGCAGAGGGCTGGGAAGCTTCTCTGGCTCTGGCTTTTCAGCCTGAACCTCTCCTCCCACGACAAGAACTGT 2368 
GTTTGCCTTGAAGGAGCCCACCTCGGCTCTGCCCTCCTGAATTTGCCTTAGGGAGAGTATATGCTCCCCCCTGGGGGGGCACCCTGATAA 2458 
CCTTGAGACTTGGTTCCTTCTTCTTAGGCTCCTAAGAAGCCCAGAAGCCTAAAAGCCCTCCCCCATCCTAGCATTCTGCAGCTTCTTTCC 2548 
TCTAGGAAGGGGCCCTGGACATGTCTCACCTAGGACCAAAGGGAGCCTGCCAAGCTCCCCTCCCAATGCTAGTGACTAGCTCCTCCTTCC 2638 
CTAGGCTGCCCATATTCTCTTTCAGTGCCCCATAGGTCTCCGGAGGCTGGCACTCCCCGCCCGCCCCCACCCCCAGCTTCTGCAGTCCTT 2728 
GTCCCAACTCTTAATGACATGGGGCAGACACACCCACTAGGGTACCAGAGGTCCCTGGGCAGTGTGTGTGATTGTGGATGCTCAGCAGGT 2818 
CACAGACCAAGCTTATGGGCTTCCTCCCTTCCAGATTCCTGTCCCCACACAACACTACTAGGCTCAGGCCAGCAGCTCACCCCACACAGA 2908 
GTCTGTGGAACCCCCAAAGGAATCCACTAAGGCCTGGGAAGTCTGTCCTAAGGGTGAAAGGGGCCCTCCCTTCCTCTTCTCATCCTGGAG 2998 
TCAGCAGGAGGCTTCTGTGGGAAATGGTACTGTACAGCTGTGGCTCTGTCTCCTCTGCCTCCCTAAAGCCTTGAGCAGTAAAGGGCTGCC 3088 
AGCCAGGATCCTCTGGGTCACCGCCGCTTTCCAAGTGGTGGATTCTTATAGCCTGGCACTAGAGGTGACAGATCGGAGGGGCATGTCCTG 3178 
CAGCACTCTAGATGTCCCCTCTGCAGAACCTGAGAGTCAGCAAGGGGTGGGGCGTCCACCCCCCCACTCCCCATCGTTTAGTTCTGTAGA 3268 
TAATCAGCACTGATTAAATGTCCAGCCAGCGAGCGTGGCTGCACTTGTACGCTCAAAAAAAAAAAAAACCG 3339 
B 
signal Propeptide r—• Catalytic Hinge Hemopexin-like 
■y 
Ins 1 Ins 2 
S* 01 ^366 
Transmembrane 
I Cytoplasmic 
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Fig. 1. The nucleotide and predicted protein sequences of a new mouse MMP gene. A: The nucleotide sequence of 3.3 kb (accession number 
D86332) coding for the mouse MT2-MMP gene is presented. The sequence contains an open reading frame that starts at the ATG codon and 
terminates at the TGA codon. A conserved PRCGVPD sequence in the propeptide domain which is part of the cysteine switch mechanism im-
portant in enzyme activation is boxed. A potential furin-sensitive site, RXKR, is underlined with a dotted line. An eight amino acid residues 
insertion in the catalytic domain is underlined with arrows. Zinc binding site is single underlined. The predicted transmembrane domain at the 
C terminus is double underlined. B: Schematic illustration of the domain structure of mouse MT2-MMP. Domains are indicated above the il-
lustration. Insertions unique to MT-MMPs are indicated by the shaded boxes (Ins 1, 2 and 3). 
Fig. 2. Detection of human and mouse MT2-MMP by Western blotting. COS-1 cells were transiently transfected with human MT1-, MT2-, 
MT3-MMP and mouse MT2-MMP plasmids as follows: lane 1, no DNA; lane 2, human MT1-MMP; lane 3, human MT2-MMP; lane 4, 
mouse MT2-MMP; lane 5, human MT3-MMP. Cell lysates were prepared and examined by Western blotting using mAbs as described in Sec-
tion 2. 
clones. Sequence analysis revealed that six of them corre-
sponded to the mouse MT1-MMP gene [3] and the gene 
was used for the analysis of MT1-MMP expression during 
mouse embryogenesis as reported previously [16]. The nucleo-
tide sequences of the other two clones were different from 
mouse MT1-MMP showing 62% homology to the probe se-
quence while mouse MT1-MMP showed 88% homology. 
Since these clones did not contain the entire open reading 
frame (ORF), we used one of the fragments for further screen-
ing of the library under high stringency conditions to obtain a 
cDNA clone that contains an intact ORF for MMP. 
A new cDNA clone consisting of 3339 bp and containing 
an ORF coding for a protein of 657 amino acids was obtained 
(Fig. 1). The predicted protein has a modular domain struc-
ture similar to MT-MMPs including a transmembrane do-
main and a cytoplasmic tail at the C-terminus (Ins 3). MT1-
MMP, MT2-MMP and MT3-MMPs have two unique inser-
tions (Ins 1 and 2) compared to other MMPs [4]. Ins 1 is 
between propeptide and catalytic domains and Ins 2 is in 
the catalytic domain. Both of these insertions were also found 
in the predicted protein. Comparison of the amino acid se-
quence of the newly isolated mouse MT-MMP to human MT-
MMPs showed the highest homology to human MT2-MMP 
(87%) with homology of 52% for MT1-MMP, 50% for MT3-
MMP and 29% for MT4-MMP. Accordingly, only human 
MT2-MMP cDNA clones were isolated when a human pla-
centa cDNA library was screened under a high stringency 
condition with this mouse cDNA as a probe (data not 
shown). Thus the new gene is thought to be the mouse ho-
mologue of MT2-MMP. 
To identify the product of the gene, a monoclonal antibody 
(anti-MT2-MMP, 162-4E3) was raised against a synthetic 
peptide corresponding to the insertion (Ins 2) in mouse 
MT2-MMP. Human and mouse MT-MMPs were expressed 
in COS-1 cells by transient transfection of the corresponding 
expression plasmids. Western blot analysis of the lysates dem-
onstrated that the mAb 162-4E3 recognized a 70 kDa protein 
only in the lysates of cells transfected with the human and 
mouse MT2-MMP plasmids and did not react with human 
MT1-MMP and MT3-MMP (Fig. 2). On the other hand, 
MT1-MMP and MT3-MMP were recognized as 63 and 66 
kDa proteins by mAbs 113-15E [1] and 117-4E3 [4], respec-
tively. 
MT1-MMP was first identified as a pro-gelatinase A acti-
vator [1] and, later, MT3-MMP was shown to have a similar 
activity although it was less efficient [4]. Thus we have exam-
ined whether human and mouse MT2-MMPs can activate 
pro-gelatinase A. Human and mouse MT2-MMPs were ex-
pressed in COS-1 cells together with pro-gelatinase A by tran-
sient co-transfection. The culture medium was collected and 
analyzed by gelatin zymography. Pro-gelatinase A was de-
Fig. 3. Activation of progelatinase A by human and mouse MT2-
MMPs. COS-1 cells were co-transfected with the expression plas-
mids for pro-gelatinase A and one of the human MT1-, MT2-, 
MT3-MMP or mouse MT2-MMPs. 24 h after transfection the cells 
were transferred to serum free DMEM and cultured further for 
24 h. The culture medium was collected and analyzed by gelatin zy-
mography. Lanes correspond to those in Fig. 2 except all MT-
MMP plasmids were co-transfected with gelatinase A. 
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tected as a 68 k D a band when it was expressed alone (Fig. 3). 
Co-expression of M T 1 - M M P and M T 3 - M M P generated a 
processed gelatinase A corresponding to intermediate (64 
kDa) and fully activated (62 kDa) forms. Expression of hu-
man and mouse M T 2 - M M P s also induced processing of pro-
gelatinase A (Fig. 3). Thus, although no function of human 
M T 2 - M M P has been described yet, we demonstrated that 
both human and mouse M T 2 - M M P have the ability to acti-
vate pro-gelatinase A when co-expressed in COS-1 cells. The 
substrates of M T 2 - M M P and M T 3 - M M P in E C M have not 
been determined yet either. It is possible to speculate that they 
share some common target proteins while the expression of 
the genes is regulated differently. 
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